296 completed, 122 unknown, 96 recruiting, 58 terminated. 177 Phase 2, 156 Not applicable, 134 Phase 1, 50 Phase 3, 19 Phase 4.
Follow Liver Cancer: new trials by email Literature Review of Liver Cancer trials Research Report on Liver Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) Music-assisted relaxation and imagery (MARI) - Surgery, Stomach Cancer | Not applicable | Not yet recruiting | Case Comprehensive Cancer Center | 20 | 2027-01-01 | 2026-08-05 |
| Development of a Risk Prediction Model for Immune-Targeted Therapy-Related Diarrhea in Patients With Hepatocellular Carcinoma Based on TCM Constitutional Types: A Prospective Cohort Study Liver Cancer | Not yet recruiting | Affiliated Hospital of Chengde Medical University | 500 | 2027-01-01 | 2026-08-03 | |
| Study Evaluating the Efficacy and Safety of BGB-B2033 in Participants With Advanced Hepatocellular Carcinoma BGB-B2033 - Hepatocellular Cancer, Liver Cancer | Phase 2 | Not yet recruiting | BeOne Medicines | 100 | 2026-11-30 | 2026-11-03 |
| Characterizing Tumor Hypoxia With BOLD-MRI to Predict Y-90 Treatment Response Blood oxygen level-dependent (BOLD) magnetic resonance imaging ( MRI) - Hepatocellular Carcinoma, Liver Cancer | Not applicable | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 12 | 2026-11-01 | 2026-11-04 |
| Immune-Related Adverse Events and Clinical Outcomes of First-Line Immunotherapy in Egyptian Patients With Unresectable Hepatocellular Carcinoma Atezolizumab plus bevacizumab, Durvalumab Plus Tremelimumab - Hepatocellular Carcinoma, Hepatocellular Carcinoma (HCC) | Not yet recruiting | Assiut University | 294 | 2026-11-01 | 2026-10-29 | |
| Study Comparing BGB-B2033 With Sorafenib or Lenvatinib in Advanced Hepatocellular Carcinoma BGB-B2033, Lenvatinib, Sorafenib - Hepatocellular Carcinoma, Liver Cancer | Phase 3 | Recruiting | BeOne Medicines | 492 | 2026-10-23 | 2026-11-10 |
| A Retrospective Registry of Intelliblate DUAL Channel Microwave Ablation Intelliblate Microwave Ablation (MWA) System - Liver Ablation, Liver Cancer | Not yet recruiting | Varian, a Siemens Healthineers Company | 63 | 2026-10-01 | 2026-10-28 | |
| Patients With Hepatocellular Carcinoma (HCC) Fecal microbiota transplantation performed via colonoscopy., Simulated Colonoscopy With Placebo Capsules in Addition to Standard Treatment - Hepatocellular Carcinoma, Hepatocellular Cancer | Not applicable | Not yet recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 52 | 2026-09-01 | 2026-07-21 |
| Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer [64Cu]CM500, [68Ga]CM500, PET/MR - Bladder Cancer, Glioma | Early Phase 1 | Not yet recruiting | Lumina Pharmaceuticals Inc | 40 | 2026-09-01 | 2026-08-28 |
| A Prospective, Single-Arm, Open-Label Clinical Study of the Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Targeted Therapy and a PD-1 Inhibitor in Patients With Postoperative Hepatocellular Carcinoma and Microvascular Invasion HAIC, Donafenib + lenvatinib+apatinib, Sintilimab+camrelizumab+tislelizumab - Liver Cancer | Phase 4 | Not yet recruiting | Zhai Wenlong | 40 | 2026-08-30 | 2026-08-27 |
| SL-28 for Advanced Solid Tumours SL-28 - Head & Neck Cancer, Pancreas Carcinoma | Phase 1 / Phase 2 | Recruiting | Second Life Therapeutics | 60 | 2026-08-14 | 2026-09-15 |
| Precision Navigation to Improve Community Cancer Screening Participation Precision Navigation Intervention, Usual Health Education - Cancer Screening, Lung Cancer | Not applicable | Recruiting | Hunan Cancer Hospital | 1500 | 2026-08-04 | 2026-09-18 |
| YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies YMN-136 vaccine - Liver Cancer, Pancreatic Cancer | Phase 1 | Recruiting | West China Hospital | 9 | 2026-08-01 | 2026-08-13 |
| HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma DEB-TACE, Toripalimab, Lenvatinib - Liver Cancer | Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | 29 | 2026-06-30 | 2026-07-06 |
| Erector Spinae Plane Block Versus Thoracic Epidural Analgesia for Open Liver Resection Continuous Erector Spinae Plane block, Thoracic Epidural Analgesia (TEA) - Liver Neoplasms, Hepatic Resection | Not applicable | Completed | Nguyen Toan Thang | 60 | 2026-06-15 | 2026-09-24 |
| Protoacoustic Imaging For 3D Mapping Radiacoustic Imaging w/Ultrasound. - Proton Therapy, Radiation Therapy, Secondary Skin Reactions | Recruiting | University of Oklahoma | 24 | 2026-06-10 | 2026-09-22 | |
| Digitally Supported Prehabilitation Before Major Visceral Cancer Surgery Digitally Supported Multimodal Prehabilitation - Gastrointestinal Neoplasms, Pancreatic Neoplasms | Not applicable | Not yet recruiting | Ludwig Boltzmann Institute for Digital Health and Prevention | 30 | 2026-06-01 | 2026-06-18 |
| 68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC) Lu-PSMA-617 - Liver Cancer, Hepatocellular Carcinoma | Phase 2 | Recruiting | Melissa Lumish | 10 | 2026-06-01 | 2026-05-08 |
| China Metastatic Liver Cancer Clinical Registry Cohort Database Standard of Care for Metastatic Liver Cancer - Liver Metastases, Metastases to Liver | Recruiting | Anhui Provincial Hospital | 2000 | 2026-06-01 | 2026-05-22 | |
| HAIC-TACE Plus Apatinib and Camrelizumab for Liver Cancer HTAC, HAC, TAC - Liver Cancer | Phase 1 / Phase 2 | Not yet recruiting | Shanghai Zhongshan Hospital | 315 | 2026-06-01 | 2026-05-20 |
Showing 20 of 659. Sign in to see all of them.
Liver Neoplasms (659) · Carcinoma, Hepatocellular (248) · Pancreatic Neoplasms (110) · Stomach Neoplasms (86) · Lung Neoplasms (85) · Esophageal Neoplasms (68) · Breast Neoplasms (62) · Colorectal Neoplasms (62) · Ovarian Neoplasms (48) · Kidney Neoplasms (47) · Head and Neck Neoplasms (45) · Bile Duct Neoplasms (42) · Colonic Neoplasms (42) · Neoplasms (39) · Gallbladder Neoplasms (37)
Neoplasms by Site (659) · Digestive System Diseases (658) · Digestive System Neoplasms (658) · Liver Diseases (639) · Neoplasms (620) · Neoplasms by Histologic Type (335) · Neoplasms, Glandular and Epithelial (303) · Carcinoma (279) · Adenocarcinoma (271) · Gastrointestinal Diseases (143) · Endocrine System Diseases (135) · Endocrine Gland Neoplasms (133) · Gastrointestinal Neoplasms (124) · Pathological Conditions, Signs and Symptoms (118) · Pancreatic Diseases (111)
Sorafenib (29) · Bevacizumab (21) · Oxaliplatin (18) · Doxorubicin (17) · Gemcitabine (15) · Cisplatin (13) · Fluorouracil (13) · Capecitabine (12) · Carboplatin (10) · Radiofrequency Ablation (10) · Radiosurgery (10) · Radiotherapy (9) · Hepatectomy (8) · Leucovorin (8) · lenvatinib (8)
M.D. Anderson Cancer Center (21) · Memorial Sloan Kettering Cancer Center (21) · National Cancer Institute (NCI) (14) · National Institutes of Health Clinical Center (CC) (13) · Sun Yat-sen University (12) · National Taiwan University Hospital (11) · Stanford University (11) · West China Hospital (9) · Alliance for Clinical Trials in Oncology (8) · RenJi Hospital (8) · Fuda Cancer Hospital, Guangzhou (7) · Guangxi Medical University (7) · Northwestern University (7) · Washington University School of Medicine (7) · H. Lee Moffitt Cancer Center and Research Institute (6)
United States (293) · China (135) · France (34) · Taiwan (29) · Canada (26) · United Kingdom (21) · Italy (20) · South Korea (18) · Hong Kong (16) · Singapore (15) · Australia (14) · Germany (14) · Belgium (11) · Netherlands (11) · Spain (9)
Tim F Greten, M.D. (5) · Zhenfeng Zhang, MD, PhD (5) · Samuel So (4) · Steven R. Alberts, MD (4) · Bert H. O'Neil, MD (3) · Bradford J Wood, M.D. (3) · Chunling Jiang, PhD (3) · Dieter Koeberle, MD (3) · Jean-Francois Dufour, MD (3) · Jennifer Knox, MD (3) · Jennifer Temel, MD (3) · Riad Salem, MD (3) · Yong Xu, Dr (3) · Alexandre Chan, PharmD, MPH (2)
PMID 23683550, PMID 10400029, PMID 11074877, PMID 11419162, PMID 12076865, PMID 12143206, PMID 12163951, PMID 12196376, PMID 14673042, PMID 14762849, PMID 14762851, PMID 15454134, PMID 15508084, PMID 15558814, PMID 15967833, PMID 16234526, PMID 16249352, PMID 16495695, PMID 16914576, PMID 17449585, PMID 17634485, PMID 18019945, PMID 18060598, PMID 18196204, PMID 18202543, PMID 18281544, PMID 18349311, PMID 18504614, PMID 18520231, PMID 18669454, PMID 18669455, PMID 19023677, PMID 19075272, PMID 19094562, PMID 19212279, PMID 19300227, PMID 19387732, PMID 19399502, PMID 19430790, PMID 19638109, PMID 19698857, PMID 19766639, PMID 19846851, PMID 19908093, PMID 20007735, PMID 20010173, PMID 20044751, PMID 20063546, PMID 20137393, PMID 20203173
P30CA016672 (4), P30CA060553 (4), P30CA008748 (3), P30CA068485 (3), 2019 (2), P30CA015083 (2), P30CA016086 (2), P30CA033572 (2), P30CA036727 (2), P30CA043703 (2), U01CA079778 (2), U01CA080098 (2), 2009 (1), 2015 (1), 2016 (1)